Commerzbank
-
Louis Dreyfus Commodities Asia has sealed its $400m three year revolver, with a group of 38 banks. The loan, which was signed at the end of July, attracted mostly the company’s relationship banks, said a banker at one of the leads. -
After last week’s big bang in issuance, history was written and there was even a feeling of awe at investors' capacity for paper. And this week, supply lines continued delivering until just hours ahead of the summer break.
-
Covered bond new issue premiums fell this week as six issuers raised a collective €5.5bn in three currencies with total demand of almost €8bn.
-
Abu Dhabi's Union National Bank is looking for a margin of 75bp over Libor for a $500m three year loan, according to a banker on the deal.
-
International schools operator Cognita on Tuesday began roadshowing its £280m bond, becoming the second borrower from the private education industry in the speculative grade market this year.
-
Germany dominated covered bond supply this week with four banks raising €2.5bn after collecting orders of nearly €6bn in total.
-
The primary market for peripheral European covered bonds leapt back to life this week after a 12 week hiatus, with investors queuing up to buy a series of deals that emerged in quick succession.
-
German Startups Group Berlin withdrew its IPO this week, having failed to achieve coverage on the deal, according to a person close to the situation.
-
German Startups Group, the Berlin-based venture capital firm, had been due to finish bookbuilding its IPO on Thursday, but instead extended the sale until Tuesday 21 July.
-
German Startups Group had been due to finish bookbuilding its IPO on Thursday, but instead extended the sale until Tuesday 21 July.
-
Deutsche Pfandbriefbank, nationalised during the financial crisis, made its stockmarket debut on Thursday and traded up 6.5%, after pricing its IPO on Wednesday evening at the bottom of the range.
-
German wheelchair maker Sunrise Medical’s €315m acquisition loan has begun trading in secondary markets after being priced in line with initial guidance.
